NCT05037461View on ClinicalTrials.gov

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions

Neuroendocrine Tumor of PancreasMultiple Endocrine Neoplasia Type 1

Interventions

RADIATION

High-dose-high precision MR-guided radiotherapy

MR-guided radiotherapy as described in the group information

Trial Locations (1)

3584 CX

RECRUITING

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Radboud University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

lead

J.M. de Laat

OTHER